10 completed, 3 terminated, 3 unknown, 1 active not recruiting. 19 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 19 | Completed 10, Terminated 3, Unknown 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Chronic Myeloid Leukemia: new trials by email Literature Review of Chronic Myeloid Leukemia trials Research Report on Chronic Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion CliniMACS - Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission | Not applicable | Active not recruiting | Baylor College of Medicine | 3 | 2023-12-06 | 2026-10-08 |
| MargheRITA (Remote Intelligence for Therapeutic Adherence) RITA (App) - Multiple Myeloma, Solitary Plasmacytoma | Not applicable | Completed | Advice Pharma Group srl | 124 | 2022-06-04 | 2024-11-06 |
| Interest of PHARMaceutical Conciliation to Understand Drug Interactions, Phytotherapy, and Targeted Therapies in Chronic Myeloid Leukemia Pharmaceutical intervention - Chronic Myeloid Leukemia | Not applicable | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 100 | 2022-01-27 | 2026-10-13 |
| Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications Patient Reported Outcome Measure (PROM), Comprehensive Medication Review (CMR), Communications between oncology and primary care pharmacists - Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia | Not applicable | Terminated | University of Michigan Rogel Cancer Center | 6 | 2021-03-26 | 2022-11-22 |
| Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence Patient-reported outcome measure, Comprehensive Medication Review, Pharmacist communication - Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia | Not applicable | Unknown | University of Tennessee | 30 | 2021-02-08 | 2023-12-04 |
| A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors Online Mindfulness Meditation, Internet-Based Webinars - Myeloproliferative Neoplasm, Chronic Phase Chronic Myelogenous Leukemia | Not applicable | Completed | University of California, San Francisco | 47 | 2020-09-18 | 2023-02-13 |
| Effects of a Digital Patient Platform (CMyLife) for Patients With Chronic Myeloid Leukemia (CML) on Information Provision, Patient Empowerment, Medication Compliance, Guideline Adherence and Quality of Life CMyLife - Neoplasms, Chronic Myeloid Leukemia | Not applicable | Completed | Radboud University Medical Center | 99 | 2019-07-01 | 2020-10-22 |
| To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission Stopping the standard drug therpy, Quantitative bcrabl recording every month for first 6 months - Chronic Myeloid Leukemia, Treatment Free Remission | Not applicable | Unknown | Command Hospital, India | 27 | 2017-08-01 | 2019-07-23 |
| Targeting Leukemic Stem Cell Expressing the IL-1RAP Protein in Chronic Myelogenous Leukemia (CML) biological samples - Chronic Myeloid Leukemia | Not applicable | Completed | Centre Hospitalier Universitaire de Besancon | 53 | 2015-10-14 | 2022-06-01 |
| Allo-HSCT With Alternative Donor in Treatment of Hematologic Malignancy HSCT from MSD, HSCT from MUD, HSCT from HRD - Acute Leukemia, Chronic Myeloid Leukemia | Not applicable | Completed | Nanfang Hospital, Southern Medical University | 876 | 2015-06-01 | 2020-03-05 |
| Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008 bosutinib - Chronic Myeloid Leukemia | Not applicable | Completed | Pfizer | 281 | 2013-08-28 | 2022-07-19 |
| Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients Placebo, Armodafinil - Chronic Myeloid Leukemia | Not applicable | Terminated | M.D. Anderson Cancer Center | 1 | 2011-05-01 | 2015-12-08 |
| Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib Imatinib treatment discontinuing - Chronic Myeloid Leukemia, Imatinib | Not applicable | Unknown | Seoul St. Mary's Hospital | 50 | 2010-06-01 | 2014-01-13 |
| Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy) - Acute Myeloid Leukemia, Lymphoblastic Leukemia | Not applicable | Completed | University of Illinois at Chicago | 14 | 2009-09-01 | 2021-06-14 |
| Telemonitoring Study - for Chronic Myeloid Leukemia (CML) no access to eMedonline, eMedonline access - Chronic Myeloid Leukemia | Not applicable | Terminated | Rex Cancer Center, Raleigh, NC | 14 | 2009-04-01 | 2018-08-13 |
| Impact of the Inhibitors of Tyrosine Kinase on the Male Fertility Imatinib treatment - Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors | Not applicable | Completed | Assistance Publique - Hôpitaux de Paris | 2 | 2008-10-01 | 2011-03-29 |
| Natural Killer Index From Hematopoietic Stem Cell Graft Blood test - Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia | Not applicable | Completed | Nantes University Hospital | 92 | 2007-04-01 | 2026-09-14 |
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate Imatinib Mesylate (Gleevec) - Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia | Not applicable | Completed | M.D. Anderson Cancer Center | 125 | 2001-06-01 | 2022-01-04 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (19) · Leukemia (5) · Leukemia, Myeloid, Acute (5) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (4) · Leukemia, Lymphocytic, Chronic, B-Cell (3) · Lymphoma, Non-Hodgkin (3) · Anemia, Refractory, with Excess of Blasts (2) · Hematologic Diseases (2) · Hematologic Neoplasms (2) · Hodgkin Disease (2) · Leukemia, Myeloid, Chronic-Phase (2) · Multiple Chronic Conditions (2) · Multiple Myeloma (2) · Myelodysplastic Syndromes (2) · Myeloproliferative Disorders (2)
Bone Marrow Diseases (19) · Chronic Disease (19) · Disease Attributes (19) · Hemic and Lymphatic Diseases (19) · Leukemia, Myeloid (19) · Neoplasms by Histologic Type (19) · Pathologic Processes (19) · Pathological Conditions, Signs and Symptoms (19) · Neoplasms (18) · Hematologic Diseases (17) · Myeloproliferative Disorders (17) · Leukemia (14) · Immune System Diseases (8) · Immunoproliferative Disorders (7) · Leukemia, Lymphoid (7)
Patient Reported Outcome Measures (2) · Antilymphocyte Serum (1) · Cyclosporine (1) · Hematologic Tests (1) · Imatinib Mesylate (1) · Methotrexate (1) · Modafinil (1) · Mycophenolic Acid (1) · bosutinib (1)
M.D. Anderson Cancer Center (2) · Advice Pharma Group srl (1) · Assistance Publique - Hôpitaux de Paris (1) · Baylor College of Medicine (1) · Centre Hospitalier Universitaire de Besancon (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Command Hospital, India (1) · Nanfang Hospital, Southern Medical University (1) · Nantes University Hospital (1) · Ossium Health, Inc. (1) · Pfizer (1) · Radboud University Medical Center (1) · Rex Cancer Center, Raleigh, NC (1) · Seoul St. Mary's Hospital (1) · University of California, San Francisco (1)
United States (9) · France (5) · China (2) · India (2) · Italy (2) · Netherlands (2) · South Korea (2) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Finland (1)
Alessandro Flavio Ferri (1) · Carmen Escalante, MD (1) · Damiano Rondelli, MD (1) · Erin Morales, MD (1) · Jacqueline Mandelbaum, Dr (1) · Jorge Cortes, MD (1) · Karen Farris, PhD (1) · Kelly Schoenbeck, MD (1) · Norbert Ifrah, MD (1) · Patrice Chevallier, MD (1) · Qifa Liu (1) · Robert Wehbie, MD (1)
PMID 25234438, PMID 26888022, PMID 27798515, PMID 35235189, PMID 36890512, PMID 37335960, PMID 41894682